• RSS
  • Twitter
  • FaceBook
Home > White Papers > KPMG > Independence, in name and fact: Global Pharmaceutical Manufacturer

Independence, in name and fact: Global Pharmaceutical Manufacturer

By: KPMG
KPMG

The leadership of a new, marquee pharma manufacturer approached KPMG with a paradox: It was certainly marquee, but not new. As the highly publicized spin-off of a global health services conglomerate, the company began life with $18 billion in annual revenues, an established product pipeline and instant membership in the S&P 100. Reliant on the back office functions of its parent, it needed to quickly acquire the back office sinews of a truly stand-alone company: ERP systems and core processes for finance, operations and human resources. 

During an intensive three-year engagement, KPMG brought the vision of the company’s leaders to life, working towards a target operating model through the disciplined implementation of new systems, processes, training and staffing. The multidisciplinary approach eventually touched the lives of every one of the company’s 21,000 employees, in 170 countries. And as KPMG’s delivered tangible results, something intangible emerged – a new company culture, independent in name, spirit and operational fact.

We know how to get things done.

Email this page
Published:  Sep 17, 2018
Length:  1
Type:  White Paper
Tags : 



Community Area

Log in | Register

Solution Center

Follow TechGenix on Twitter